Stereotaxis STXS Stock
Stereotaxis Price Chart
Stereotaxis STXS Financial and Trading Overview
| Stereotaxis stock price | 2.91 USD |
| Previous Close | 2.25 USD |
| Open | 2.28 USD |
| Bid | 2.19 USD x 900 |
| Ask | 2.2 USD x 500 |
| Day's Range | 2.19 - 2.29 USD |
| 52 Week Range | 1.54 - 2.72 USD |
| Volume | 114.03K USD |
| Avg. Volume | 394.02K USD |
| Market Cap | 198.55M USD |
| Beta (5Y Monthly) | 1.508 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.29 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.5 USD |
STXS Valuation Measures
| Enterprise Value | 194.06M USD |
| Trailing P/E | N/A |
| Forward P/E | -12.222222 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.2174397 |
| Price/Book (mrq) | 66.66667 |
| Enterprise Value/Revenue | 7.054 |
| Enterprise Value/EBITDA | -8.635 |
Trading Information
Stereotaxis Stock Price History
| Beta (5Y Monthly) | 1.508 |
| 52-Week Change | 21.62% |
| S&P500 52-Week Change | 19.28% |
| 52 Week High | 2.72 USD |
| 52 Week Low | 1.54 USD |
| 50-Day Moving Average | 2.24 USD |
| 200-Day Moving Average | 2.12 USD |
STXS Share Statistics
| Avg. Volume (3 month) | 394.02K USD |
| Avg. Daily Volume (10-Days) | 1.01M USD |
| Shares Outstanding | 90.25M |
| Float | 60.59M |
| Short Ratio | 13.46 |
| % Held by Insiders | 29.61% |
| % Held by Institutions | 44.32% |
| Shares Short | 3.94M |
| Short % of Float | 6.87% |
| Short % of Shares Outstanding | 4.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1096:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -92.18% |
| Operating Margin (ttm) | -79.34% |
| Gross Margin | 53.40% |
| EBITDA Margin | -81.69% |
Management Effectiveness
| Return on Assets (ttm) | -34.74% |
| Return on Equity (ttm) | -179.82% |
Income Statement
| Revenue (ttm) | 27.51M USD |
| Revenue Per Share (ttm) | 0.32 USD |
| Quarterly Revenue Growth (yoy) | 8.59% |
| Gross Profit (ttm) | 14.69M USD |
| EBITDA | -22474000 USD |
| Net Income Avi to Common (ttm) | -26652000 USD |
| Diluted EPS (ttm) | -0.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.6M USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 5.87M USD |
| Total Debt/Equity (mrq) | 71.77 USD |
| Current Ratio (mrq) | 1.07 |
| Book Value Per Share (mrq) | 0.033 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7930000 USD |
| Levered Free Cash Flow (ttm) | 6.07M USD |
Profile of Stereotaxis
| Country | United States |
| State | MO |
| City | Saint Louis |
| Address | 710 North Tucker Boulevard |
| ZIP | 63101 |
| Phone | 314 678 6100 |
| Website | https://www.stereotaxis.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 139 |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Q&A For Stereotaxis Stock
What is a current STXS stock price?
Stereotaxis STXS stock price today per share is 2.91 USD.
How to purchase Stereotaxis stock?
You can buy STXS shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Stereotaxis?
The stock symbol or ticker of Stereotaxis is STXS.
Which industry does the Stereotaxis company belong to?
The Stereotaxis industry is Medical Instruments & Supplies.
How many shares does Stereotaxis have in circulation?
The max supply of Stereotaxis shares is 91.38M.
What is Stereotaxis Price to Earnings Ratio (PE Ratio)?
Stereotaxis PE Ratio is now.
What was Stereotaxis earnings per share over the trailing 12 months (TTM)?
Stereotaxis EPS is -0.29 USD over the trailing 12 months.
Which sector does the Stereotaxis company belong to?
The Stereotaxis sector is Healthcare.
Stereotaxis STXS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite Total Return XCMP | 29137.78 USD — |
+0.62
|
— — | 29019.72 USD — | 29409.52 USD — | — - | — — |
- {{ link.label }} {{link}}


